Moreover, an overactive JAK/STAT signaling pathway is a significant factor in the development and worsening of hepatocellular carcinoma, potentially serving as a key biomarker for assessing the severity and predicting the outcome of this type of liver cancer (Lokau et al., 2019; Zhao et al., 2021). This evidence concerns the gene SOAT1 and hepatocellular carcinoma.